Header cover image
  • Investing Ideas
  • Danish Pharmaceuticals & Biotech Large Cap High Growth Potential

Danish Pharmaceuticals & Biotech Large Cap High Growth Potential

Results

1

0 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

1 companies

Genmab

Market Cap: DKK 117.3b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

GMAB

DKK 1,904.50

7D

-2.7%

1Y

26.6%